Home
About
Leadership
Medical Advisory Board (AC5)
Scientific & Clinical Advisors
Corporate Mission
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
05/3/21
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
04/27/21
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
04/19/21
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
03/2/21
Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021
02/18/21
Arch Therapeutics Announces Closing of $6.9 Million Private Placement
02/12/21
Arch Therapeutics Announces $6.9 Million Private Placement
01/5/21
Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021
01/4/21
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.
12/11/20
Arch Therapeutics to Present at the 13th Annual LD Micro Main Event Conference
11/10/20
Arch Raises Approximately $1.1 Million with Convertible Note Issuance
<< Previous
1
2
3
4
5
6
7
8
9
10
...14
Next >>
Show All
